Anna Williamson is a Senior Manager in the Business Development Department at Genentech.  Anna’s responsibilities include sourcing, evaluating, and in-licensing research technologies and therapeutic products.  While at Genentech, Anna has developed strategic collaborations with academic institutions and with companies such as Curis, Sangamo, Abbott and Symphogen. Prior to joining Genentech in 2004, Anna worked at the University of California Office of Technology Transfer where she was responsible for managing and out-licensing a portfolio of life sciences inventions from multiple UC campuses.  Anna holds a BA in Natural Sciences and a Ph.D. in Neuroscience from the University of Cambridge, UK, and carried out post-doctoral research at the University of Colorado and the University of California, San Francisco.